Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061506) titled 'Study of Adverse Events in Fluorescein Angiography Examinations' on June 1.
Study Type:
Observational
Primary Sponsor:
Institute - Nagoya University
Condition:
Condition - Patients undergoing fluorescein angiography for retinal and choroidal diseases
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to compare the incidence and characteristics of adverse events between fluorescein angiography (FA) alone and combined fluorescein and indocyanine green angiography (FA+ICGA), and to evaluate the safety of angiographic examinations.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who underwent fluorescein angiography examinations at Nagoya University Hospital between October 1, 2014 and November 18, 2025
Patients whose examination records and adverse event information are available in the electronic medical records and examination logs
Key exclusion criteria - Cases in which angiographic examination could not be confirmed from examination records
Cases undergoing ICGA alone
Target Size - 10000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 05 Month 10 Day
Anticipated trial start date - 2026 Year 05 Month 10 Day
Last follow-up date - 2028 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070382
Disclaimer: Curated by HT Syndication.
